3 takeaways from a cardiologist and ‘SuperAgers' researcher on how to live longer and healthier
In 2007, researchers were on a mission to understand why some people become 'SuperAgers'—those who live to their 80s without major chronic conditions and have the brain health of someone much younger. Is it genetics? Lifestyle? Luck?
Nearly two decades later, the team was surprised. 'We didn't find these gene variants that we thought we might find,' Dr. Eric Topol, a cardiologist and founder of the Scripps Research Translational Institute, which conducted the study, tells Fortune.
This cohort of over 1,000 people with the average age of 87, who Topol refers to as 'the wellderly,' helped scientists uncover a new meaning of 'SuperAgers'—one that gives much more weight to lifestyle than previously thought.
'There's only a small component here that's actually genetic. It's been overestimated,' Topol says. 'I was personally relieved because I have such a terrible family history. That felt good, that, hey, maybe I'm not destined to suffer the same illnesses.'
Topol's latest book, Super Agers: An Evidence-Based Approach to Longevity, is the result of decades of work and highlights the keys to living longer.
In a world where longevity has become a wellness megatrend, dominated by a growing number of companies offering scans, tests, lifestyle hacks, and more, Topol is eager to cut through the noise. 'We have a lot of things that are without any basis out there, and some of it is egregious,' he says, nodding to companies solely selling supplement subscriptions, full-body MRIs, and not widely recommended medicines under the guise of longevity experts.
For Topol, reversing aging or gamifying longevity isn't the goal; instead, the focus is on reducing the risk of developing chronic diseases that are more common as we get older.
Here are three key takeaways from Topol's years of observing SuperAgers:
Exercise is an age-old pillar of health and for good reason. Exercise reduces the risk of heart disease, helps keep the brain active and fight cognitive decline, and decreases the risk of age-related falls and frailty.
'Exercise is extraordinary. It works across all three age-related diseases,' Topol says of cancer, heart disease, and dementia, highlighting it is the most effective way to keep the immune system healthy and fight disease.
As a cardiologist, Topol has always championed aerobic exercise to reduce the risk of heart disease. Since studying the 'wellderly,' he encourages adding strength training, including grip strength exercises and resistance training, to counter age-related muscle and bone loss and improve balance and mobility.
The Mediterranean diet is the standard diet in many of the world's blue zones. The diet, consisting of whole foods, colorful fruits and vegetables, lean meats, whole grains, olive oil, and minimal dairy, is the diet that's most protective against chronic diseases, Topol says. Research suggests that the diet is associated with improving bone, heart, and brain health and reducing cancer risk.
'It's the best backed-up diet we have,' Topol says of his research on aging thus far. 'That diet has consistently been shown to be a winner.'
The diet also de-emphasizes ultra-processed foods, or what Topol refers to as UFOs, which can, when consumed routinely, increase the risk of chronic conditions like heart disease and stroke, and lead to early mortality.
Age-related diseases usually progress within 20 years. Topol says that many people are unaware of their risks for age-related diseases, and therefore, aren't making lifestyle changes that could help mitigate those risks.
'How will we be able to forecast very reliably when, who, and what of these conditions we will be at risk for so we can prevent them for the first time?' he asks. More preventative screenings are going to become mainstream, he says.
While the traditional health system treats patients after they are sick, Topol hopes that progressive medicine and technology help quantify people's risk to allow them to take more control earlier. If someone recognizes that they have an increased risk for Alzheimer's, using a brain clock or blood test to detect amyloid plaques associated with the disease, they may be more apt to adopt a healthier lifestyle, Topol says.
'We can get ahead of it, so that you never have to face that disease in your lifetime,' he says. 'We can make big inroads by preventing age-related diseases.'
This story was originally featured on Fortune.com
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Fox News
an hour ago
- Fox News
Common menopause medication might prevent breast cancer while treating hot flashes
A drug intended to treat menopause symptoms could double as breast cancer prevention. New research from Northwestern University in Illinois found that Duavee, a Pfizer-made drug, "significantly reduced" breast tissue cell growth, which is a major indicator of cancer progression. A phase 2 clinical trial included 141 post-menopausal women who had been diagnosed with ductal carcinoma in situ (DCIS), also known as stage 0 breast cancer, according to a press release from Northwestern. This non-invasive breast cancer affects more than 60,000 American women each year, often leading to an outcome of invasive breast cancer. The women were separated into two groups — one received Duavee and the other took a placebo for a month before undergoing breast surgery. Duavee is a conjugated estrogen/bazedoxifene (CE/BZA) drug, which combines estrogen with another medication that minimizes the potential harmful side effects of the hormone. "The key takeaway from the study is that CE/BZA slows the growth (proliferation) of cells in milk ducts of DCIS that expressed the estrogen receptor significantly more than placebo," Dr. Swati Kulkarni, lead investigator and professor of breast surgery at Northwestern University Feinberg School of Medicine, told Fox News Digital. Another major finding is that the quality of life did not differ significantly between the two groups, but patients who took the CE/BZA reported fewer hot flashes during the study, she noted. "This would be expected, as the drug is FDA-approved to treat hot flashes." "What excites me most is that a medication designed to help women feel better during menopause may also reduce their risk of invasive breast cancer." Kulkarni presented the study last week at the American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago. The findings are preliminary and have not yet been published in a medical journal. "What excites me most is that a medication designed to help women feel better during menopause may also reduce their risk of invasive breast cancer," said the doctor, who is also a Northwestern Medicine breast surgeon. Women who face a higher risk of breast cancer — including those who have experienced "high-risk lesions" — and who also have menopausal symptoms are most likely to benefit from the drug, according to Kulkarni. "These women are typically advised against standard hormone therapies, leaving them with few menopausal treatment options," the release stated. The researchers said they are "encouraged" by these early results, but more research is required before the medication can be considered for approval as a breast cancer prevention mechanism. "Our findings suggest that CE/BZA may prevent breast cancer, but larger studies with several years of follow-up are needed before we would know this for sure," Kulkarni told Fox News Digital. Dr. Sheheryar Kabraji, chief of breast medicine at the Roswell Park Comprehensive Cancer Center in Buffalo, New York, was not involved in the study but commented on the findings. "While intriguing, this study is highly preliminary, and more research will be needed before we can conclude that conjugated estrogen/bazedoxifene (CD/BZA), a form of the hormone estrogen commonly prescribed to address symptoms of menopause, prevents invasive breast cancer or is effective at reducing cancer risk," she told Fox News Digital. Kabraji also noted that the study focused on reducing levels of one specific protein, "which does not always predict reduced recurrence of breast cancer." "This study did not directly show that CE/BZA treatment reduces the risk of DCIS recurrence or development of invasive cancer," she noted. "While intriguing, this study is highly preliminary." "Importantly, however, patients who received this therapy experienced no worsening of quality of life, and saw improvement in vasomotor symptoms, such as hot flashes. If found to be effective in preventing breast cancer, CE/BZA is likely to have fewer side effects than current medications used for breast cancer prevention." For more Health articles, visit Lead researcher Kulkarni emphasized that this medication is not for the treatment of invasive breast cancer or DCIS. "Right now, we can say that women who are concerned about their risk of developing breast cancer can consider this medication to treat their menopausal symptoms," she added.
Associated Press
an hour ago
- Associated Press
New online tool helps women on Medicaid find prenatal care and family planning
At the University of Mississippi Medical Center, one researcher's full-time job for the past nine months has been to find out which clinics around the state offer different kinds of women's health care, and whether they accept various forms of Medicaid. The final result is a recently launched database aimed at helping women locate the nearest clinic that can offer the care they need. The work that went into creating it highlights a pervasive problem: Even making an appointment can be a barrier that keeps women from improving their lives. 'We Need to Talk' is a compilation of all Mississippi clinics offering prenatal care – specifying which ones also offer family planning, and whether they take Medicaid insurance, Medicaid waivers and see women whose Medicaid applications are pending. There is also a hotline designed to give additional support to anyone having questions or feeling overwhelmed about the process. 'Having gone through the work, it was remarkable. It wasn't easy to figure out where you should go for care,' said Dr. Thomas Dobbs, former state health officer and dean of the John D. Bower School of Population Health at UMMC, who oversaw the project. 'And that should be one of the most basic bits of information we have.' The idea was born from the recent 900% increase in babies born with syphilis, Dobbs explained, which he called a 'canary in a coal mine' signaling more danger to come. An investigation into the epidemic showed that one of the driving factors was delayed prenatal care, caused in large part by inaccessible information and concerns about cost, Dobbs said. Finding reproductive and prenatal care can be difficult for several reasons. For one thing, there are many different kinds of clinics in Mississippi, making it hard for patients to know what to search for. The list includes federally qualified health centers, county health department clinics and private OB-GYNs. Another reason is that many clinics don't specify online whether they take Medicaid, much less what their policy is on specific or temporary Medicaid coverage. Calling doesn't always guarantee patients a comprehensive or accurate answer. The new database is an initiative of UMMC's Myrlie Evers-Williams Institute – housed in the Jackson Medical Mall – which is committed to eliminating health disparities by studying the intersection of health and social issues. The institute has a clinic on site that practices what's called 'social medicine,' a key element of eliminating those disparities, the institute's executive director Victoria Gholar explained. 'If you have a patient who has asthma and they're living in a situation where mold is in their environment, it will really be hard for them to get better,' Gholar said. 'Or, if we have a patient who has to use an electronic (medical) device, and their electricity is no longer available because they weren't able to take care of their utility bill, then we try to work with them and connect them to resources that might be able to help.' The institute employs a wide range of professionals who work on health from a non-clinical standpoint, such as researchers, community engagers, social workers and registered dietitians. It hosts events like food drives and offers free support from budgeting strategies to meal preparation for those with conditions like diabetes or high blood pressure. Aside from knowing what to search for, finding clinics that accept Medicaid can also be complicated because Mississippi Medicaid eligibility is constantly changing for a woman based on her age and circumstance – what kinds of services she's seeking, as well as whether she's pregnant. Medicaid eligibility in Mississippi is among the strictest in the nation, with one exception – pregnant women. That means many low-income women only become eligible for Medicaid once pregnant. And since an application can take up to eight weeks to be processed, the chances that a woman in this situation will be able to use her newly acquired Medicaid insurance in the first trimester are slim. A law that would cut out this interim period and allow low-income pregnant women to be immediately seen by a doctor passed the Legislature in 2024, but was never implemented because of legislative errors. The policy went back through the Legislature in 2025, passed overwhelmingly again, but is not yet in effect. Some doctors already see women whose Medicaid application is pending, and the UMMC tool specifies at which clinics that's the case. Women of reproductive age seeking reproductive health care are also eligible for leniency in the typical Medicaid stipulations. These women can apply for a Medicaid family planning waiver, which allows them to access Medicaid for family planning purposes, even if they don't qualify for general Medicaid coverage. The income requirement for pregnancy Medicaid and the family planning waiver is a household income of less than 194% of the federal poverty level, or about $2,500 a month for one person in 2025. Dobbs, who has been the main point person on the project, said he hopes the online database is one more resource improving health care accessibility and women's health metrics in Mississippi. 'This isn't about getting patients to UMMC at all,' Dobbs said. 'It's about empowering patients to be able to get the care they need where they live.' ___ This story was originally published by Mississippi Today and distributed through a partnership with The Associated Press.
Gizmodo
an hour ago
- Gizmodo
‘Star Wars: Starfighter' Adds ‘Frankenstein' Star Mia Goth
As much as we'd love to see a Star Wars movie that just stars Ryan Gosling, Star Wars: Starfighter was never going to be that. He needs co-stars, aliens, droids, and now the very first of those may have come into view. The InSneider reports, and io9 has confirmed, that Mia Goth, the actress best known for her roles in Pearl, X, and MaXXXine, who'll soon appear Guillermo del Toro's Frankenstein and Christopher Nolan's The Odyssey, has been cast in the film. No word on what the role is, but reporter Jeff Sneider writes it is the same one Anora-star and Oscar-winner Mikey Madison was circling before moving along. This story is developing…
